Objectives : This study was performed to investigate the associations between the metabolic syndrome (MetS) and inflammatory markers.
INTRODUCTION
The metabolic syndrome (MetS) is a cluster of atherosclerotic cardiovascular disease risk factors, namely abdominal adiposity, high blood pressure, elevated triglyceride, low highdensity lipoprotein (HDL) cholesterol and impaired glucose tolerance. Furthermore, the high prevalence of MetS has made it a serious public health problem [1, 2] . The high prevalence of MetS is of considerable concern, because several studies have shown people with MetS are more likely to die prematurely and that they are at greater risk of developing diabetes mellitus and cardiovascular disease [3, 4] .
MetS is believed to be associated with chronic inflammatory response which is characterized by abnormal cytokine production and the activations of inflammatory signaling pathways [5] . Evidence for this belief is provided by observations of associations between high levels of C-reactive protein (CRP), a sensitive marker of subclinical inflammation and insulin resistance or components of MetS [2, [6] [7] [8] [9] .
Recently investigators have reported that increased white blood cell (WBC) count, a biological marker of systemic inflammation, is associated with the components of MetS, and it has been suggested that the mechanism involved is associated with the promotion of the atherothrombotic process by elevated WBC levels [10] [11] [12] .
An adipocyte-derived plasma protein, adiponectin, has also been considered to be a key molecule in the pathogenesis of MetS [2] . Adiponectin is an adipokine that is abundantly expressed in human adipose tissue and directly sensitizes the body to insulin. Furthermore elevated body fat, obesity, the presences of insulin resistance and type 2 diabetes are characterized by low plasma adiponectin concentrations [13] [14] [15] . Thus, adiponectin is currently viewed as an anti-inflammatory adipocytokine.
Accordingly, it appears reductions in antiinflammatory or an increased in proinflammatory markers underlies the development of MetS. However, to our knowledge, few studies have measured proinflammatory and anti-inflammatory markers in a single population of Koreans, and thus relations between inflammatory markers and MetS cannot be evaluated. Therefore, we conducted this cross-sectional study to investigate the independent associations between MetS and these inflammatory markers 
MATERIALS AND METHODS

I. Study Subjects
We studied a population of 1,922 Korean adults (40-69 years old), living in a rural community, in Naju, Jeollanamdo. These subjects had participated in the survey of Korean Rural Genomic Cohort Study (KRGCS, 2006) , and have been previously described in detail [16] . Of these 1,922 subjects, 344 subjects that met our exclusion criteria were excluded. In detail, the exclusion criteria were as follows: a self-reported medical history of cardiovascular diseases (CVD), cancer or chronic liver disease (n=148); an elevation of one or more of the following liver enzymes (n=59): alanine aminotransferase (ALT) twice the upper limit of normal (>85 IU/L) or aspartate aminotransferase (AST) twice the upper limit of normal (>75 IU/L); a highsensitivity CRP (hs-CRP) level of >10 mg/L (n=47) or a WBC count above or below the reference range (>10.7 or <3.8 10 3 /uL) (n=145), the latter of which implies possible systemic infection. Finally 1,578 people (612 men and 966 women) were eligible for this study. Informed consent was obtained from all subjects prior to their participation in this study, which was approved by the ethical committee.
II. Data Collection
Information on socio-demographic factors, lifestyle factors (including alcohol drinking and smoking status), self-reported medical history of CVD or cancer or chronic diseases, and current medication status, and others were obtained by interview. Smoking status was classified as non-smoker, ex-smoker, and current smoker, and alcohol drinking was classified by frequency of drinking alcohol (none, 1/month, 2-4/month, 2-3/week, 4/week).
Anthropometric measurements, including height, weight and waist and hip circumferences were taken with subjects wearing light clothing by well-trained examiners. Waist circumference was measured to the nearest 0.1 cm in the horizontal plane at the high point of the iliac crest during minimal respiration. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared. Blood pressure was measured with a mercury sphygmomanometer using right arms, in a sitting position, after a 5-min rest. Systolic and diastolic blood pressures were recorded twice and averages were used for the data analysis. Blood samples were drawn from an antecubital vein after an 8-12 hr overnight fast. Samples were stored at -70 until required for biochemical assays. Glucose, triglyceride, HDL-cholesterol, total cholesterol, ALT, and AST were measured using enzymatic methods (ADVIA 1650, Bayer, USA). Hs-CRP was analyzed by latex nephelometry. Adiponectin concentrations were determined by ELISA. WBC counts were performed using autoanalyzer.
III. Definition of MetS
MetS was defined as described by the National Cholesterol Education Program Adult Treatment Pane III (NCEP-ATP III), except for abdominal obesity by waist circumference [17] . In the present study, we used a modified waist circumference cutoff of >90 cm for men and >85 cm for women [18] . Therefore, in this study, individuals having three or more of the five following criteria were defined as having MetS: 1) high blood pressure ( 130/85 mmHg) or anti-hypertensive medication, 2) elevated fasting blood glucose ( 100 mg/dL) or anti-diabetic medication, 3) hypertriglyceridemia ( 150 mg/dL), 4) low HDLcholesterol (men, <40 mg/dL; women, <50 mg/dL), 5) abdominal obesity by waist circumference (men, >90 cm; women, >85 cm).
IV. Statistical Analysis
All statistical analyses were conducted on men and women separately, using the SPSS statistical package for Windows version 12.0 (SPSS Inc, Chicago, IL). All continuous variables are shown as means SD, except for fasting glucose, triglyceride, hs-CRP and adiponectin. To approximate normal distributions, log-transformed values were used in the analysis, and transformed back for data presentation and presented as geometric means and 95% confidence intervals (CI) for these means.
The student s t-test and the chi-square test were used to compare differences. Under a general linear model (GLM), differences between the levels of inflammatory markers in subjects with different numbers of clustered MetS components were compared by analysis of covariance (ANCOVA) after adjusting for age, smoking status and frequency of alcohol drinking as covariates. To permit direct comparison between inflammatory markers, odds ratios (ORs) and 95% CI for MetS of a 1-SD increase in WBC, log-transformed CRP and adiponectin were calculated with multivariate logistic regression analyses. ORs were evaluated using three models of independent variables in addition to sex, age, smoking status and frequency of alcohol drinking as follows -model 1, each inflammatory marker only; model 2, BMI and each inflammatory marker; model 3, BMI and all markers simultaneously.
RESULTS
The personal and clinical characteristics of the study subjects are presented in Table 1 . The prevalences of MetS in the study population were 35.8% in men, and 40.0% in women. Personal characteristics, such as, age, income, educational level, smoking and drinking status, were significantly different between the sexes. Men had higher BMI, WC, systolic blood pressure (SBP), diastolic blood pressure with the presence of MetS, even after adjusting for other inflammatory markers and related risk factors. This result supports the findings of previous studies concerning a linear independent association between WBC count and the risk of MetS [10] [11] [12] 19, 20] . As an increased WBC count may exacerbate insulin resistance and lead to MetS. In fact, the potential candidate factors that increase WBC count and exacerbate insulin resistance include promarkers WBC and adiponectin are associated with MetS in healthy Korean men and women, but that hs-CRP is associated with MetS in men only.
In this study, WBC count was not found to be significantly associated with low HDLcholesterol in either sex, or with high glucose and a raised blood pressure in men. However, an increased WBC count was found to be associated with MetS component number and (DBP), glucose, WBC and hs-CRP values, but low HDL-cholesterol and adiponectin values. Tables 2 and 3 show mean values of inflammatory markers according to the presence and absence of each MetS component, and according to the presence and absence of MetS in men and women. In men, significantly higher levels of WBC and hs-CRP were observed in those with abdominal obesity and a high triglyceride level. However, significantly lower levels of adiponectin were observed in those with any MetS component than in those without any component of MetS.
The mean values of WBC, hs-CRP and adiponectin were statistically different between men with and without MetS.
In women, mean values of WBC, hs-CRP and adiponectin were statistically different for subjects with and without a MetS component (except for low HDL-cholesterol) and for those with and without MetS.
In both sexes, as the number of clustered MetS components (ie, 0, 1, 2, 3 and 4+) increased, the adjusted means of WBC and hs-CRP increased linearly and adjusted adiponectin levels decreased linearly (Table 4) .
Associations between each inflammatory marker and MetS were evaluated by multivariate logistic regression analysis (Table  5 ). In men, associations between each inflammatory marker and MetS were statistically significant, and after adjusting for all markers and BMI, WBC count, hs-CRP and adiponectin were found to be independently associated with MetS. However, in women, the association between hs-CRP and MetS was not statistically significant after additional adjusting for BMI and all markers.
DISCUSSION
This study was performed to identify associations between inflammatory markers, namely, WBC, hs-CRP and adiponectin and MetS in an adult Korean population. The results of this study show that the inflammatory inflammatory cytokines and adipocytokines [21] . Hs-CRP is a sensitive marker of systemic inflammation, and is produced by the liver. Various epidemiological studies have reported a linear association between hs-CRP levels and metabolic disorders, including insulin resistance, MetS, and the components of MetS [2, [6] [7] [8] [9] 11, 22] . In the present study, people with MetS were found to have significantly higher hs-CRP levels than those without. Also the numbers of metabolic abnormalities were found to be strongly and positively associated with hs-CRP.
However, we did not observe an independent association between hs-CRP and MetS in the whole study population. In men, hs-CRP was found to be significantly increase the risk of MetS after adjusting for age, smoking status, drinking frequency, BMI and other inflammatory markers including WBC and adiponectin, but in women, hs-CRP was not found to be associated with MetS after adjusting for other covariates. To date the influence of sex on the association between inflammation and MetS has not been determined. Although in this study, several general factors were found to differ between men and women, and it is likely that another set of factors related to inflammation impact this situation, such as, cyclical hormonal changes associated with the menstrual cycle and subclinical autoimmune reactions [23] . Overall, available data on the effects of gender relationships between hs-CRP and MetS or atherosclerosis is reported [24, 25] .
Adiponectin, an anti-inflammatory and antiatherogenic adipocytokine was found to be more strongly associated with MetS than the other pro-inflammatory markers studies which concurs with the findings of previous studies performed in various population [2, 7, 9, 26 ] and suggests that a reduced level of protection against inflammation is more potently associated with the development of MetS than increases in the levels of pro-inflammatory proteins.
Adiponectin, is secreted predominantly by adipocytes [27] , and has been related to obesity, adipose tissue distribution, dyslipidemia, hypertension, and insulin resistance, all of which are related to clustering of the components of MetS [26] . In a recent in vitro study, adiponectin was found to increase IL-10 mRNA expression in human macrophages and to inhibit vascular inflammation -possibly by lowering hs-CRP and TNF-levels [28] . Pleiotropic functions of adiponectin on lipid and glucose metabolism and NO synthesis may also contribute to the strong association between adiponectin and MetS [2, 29] . The results of this study thus raise the possibility that adiponectin is a key player in the development of MetS and that it may be marker of the MetS. Further prospective studies are required to confirm the contribution of adiponectin to the development of MetS. If this were confirmed, it would have substantial implications for the prevention and management of MetS and atherosclerotic diseases, as these involve the suppression of inflammatory conditions [30] rather than incitement of anti-inflammatory conditions [2] . Some limitations of this study must be considered. First, this study had a crosssectional design, which prevents us from drawing inferences concerning the directionality of associations. Second, the study population was composed of individuals who living in a rural area that underwent a voluntarily health examination. Thus, the study population might have been substantially different in some respects from the general Korea population.
Nevertheless, our results show that in many people MetS is associated with inflammatory response in the subclinical or normal range. In conclusion, inflammatory markers, such as WBC and adiponectin, were associated with MetS in some Korean. The present results suggest that inflammation is substantial key mechanism in the development of MetS.
